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Mechanisms controlling the synthesis of corticotropin releasing hormone (CRH) in neonatal rats, and the ontogeny of glucocorticoid (GC) 
feedback control of hypothalamic CRH remain unknown. Specific issues are whether stress induces up-regulation of CRH gene expression 
during the first postnatal week, and the role of GC feedback, at the hypothalamic level, in the stress-hyporesponsive period. We studied the 
ontogeny of the negative feedback regulation of CRH gene expression by GC in the paraventricular nucleus (PVN). We implanted chronic 
cannulae containing a GC-receptor antagonist, RU 38486, in rats on postnatal days 3 to 13. Three days later, animals were sacrificed, and brains 
were analyzed for CRH-messenger RNA (CRH-mRNA), using semi-quantitative n situ hybridization. Animals implanted with cholesterol-con- 
taining cannulae served to evaluate the stressful effect of implantation on CRH-mRNA abundance. The presence of GC receptor messenger 
RNA (GR-mRNA) in the PVN of neonatal rats was also determined. RU 38486 did not increase CRH-mRNA abundance during the first 
postnatal week, despite the presence of GR-mRNA in the PVN. Chronic-implantation stress also failed to increase CRH synthesis. CRH gene 
expression i the PVN was enhanced in infant rats implanted with RU-38486 on postnatal day 9 or later. Cholesterol implantation on days 9, 10 
(but not later), resulted in increased PVN-CRH-mRNA. Thus, CRH-mRNA is up-regulated by chronic blockade of GC receptors only 
subsequent to the eighth postnatal day. Furthermore, such blockade does not affect the response of CRH-mRNA to chronic stress in the 
neonatal rat. 
INTRODUCTION 
Corticotropin releasing hormone (CRH) regulates 
glucocorticoid (GC) secretion from the adrenal cortex 
via adrenocorticotropic hormone (ACTH) 23. In adult 
rats, GCs have an amply documented negative feed- 
back effect on CRH synthesis in the hypothalamic 
paraventricular nucleus (PVN)  s'22'29, as well as on the 
peptide's secretion 16. This effect is at least partially 
mediated via local GC receptors m'11'19. 
During the first postnatal days, GC receptor func- 
tion, and the regulation of the hypothalamic-pitui- 
tary-adrenal axis have not been defined. In the neona- 
tal rat, both plasma GC levels 13'26 and CRH gene 
expression in the PVN 2'6 are low. GC receptor messen- 
ger RNA (GR-mRNA) has recently been demon- 
strated in rat fetal brain 9 and neonatal hypothalamus 24.
The response of brain-adrenal axis components to 
acute and chronic stress in the neonatal rat differs 
from that in the adult  12'18"21'25'26. The so-called 'stress- 
hyporesponsive period' during the first two postnatal 
weeks has been postulated to result from excess GC 
negative feedback or immaturity of stress responsive 
elements at the adrenal, pituitary or hypothalamic lev- 
els. Recently, ACTH and corticosterone (CORT) re- 
sponse to acute and repeated stress has been demon- 
strated on postnatal days 5-10 in neonatal rats 15'25'26. 
The purpose of this investigation was to study the 
ontogeny of GC feedback effect and of stress on CRH 
synthesis in the PVN. We examined the effect of a 
specific GC receptor antagonist (RU 38486) 14, im- 
planted adjacent to the PVN, on CRH messenger 
RNA (CRH-mRNA) abundance during the first two 
postnatal weeks. We examined the onset of up-regu- 
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lation of CRH-mRNA abundance and of plasma CORT 
by PVN GC receptor blockade. We determined the 
presence of GC receptor-mRNA in the PVN. Further- 
more, we studied the ffect of GC receptor blockade 
on CRH-mRNA up-regulation by chronic, implanta- 
tion-induced stress. 
MATERIALS  AND METHODS 
Animals 
Time-pregnant Sprague-Dawley rats were obtained from Zivic- 
Miller (Zelienople, PA), kept on a 12 h l ight/dark cycle and given 
access to unlimited lab chow and water. Time of birth of pups was 
determined every 12 h, and day of birth was considered ay 0; Litters 
were culled to 12 pups and mixed among experimental groups. 
Study destgn a d data presentation 
Implantation (of both sexes) was performed on postnatal days 3, 
5, 7, 8, 9, 10, 11, 12 and 13. Experimental groups consisted of: (a) 
pups implanted with RU 38486; (b) pups implanted with 
cholesterol-containing cannulae; (c) non-implanted rats. Animals 
were sacrificed 3 days later, and plasma analyzed for corticosterone 
(CORT). Plasma CORT was also measured in non-implanted pups 
aged 7 and 9 days (Fig. 2). Brains were analyzed for CRH-mRNA 
abundance in PVN. 
Cannula preparation a d implantation 
Methods of cannula preparation and implantation into the PVN 
of neonatal rats have been described zs. Briefly, cholesterol or RU 
38486 were dissolved in absolute ethanol over a hot-plate. Ethanol 
was heat-evaporated, and the crystalline residue was utilized. Cannu- 
lae were prepared from 30 gauge stainless teel hypodermic tubing 
(i.d. 0.006 inches) by cutting into appropriate lengths, and were filled 
by gently tamping one end into the crystalline steroid. The amount of 
steroid packed into the cannulae and the amount of steroid released 
from the cannulae into the brain were calculated as followsZS: 
cannulae were weighed before (1) and after (2) packing with steroid 
or cholesterol, and again when recovered after sacrifice of implanted 
rats (3). Cannulae were then immersed in ethanol to dissolve residual 
drug, and weighed a final time (4). Weight of steroid released into 
the brain was calculated using the formula: 
(Z - l ) -  (3 -4 )  
Under cold anesthesia, the steroid-containing cannula was placed 
immediately above the PVN, using a stereotaxic apparatus modified 
for neonatal rats. Age-dependent coordinates for cannula placement 
are below: 
Age(days) AP Vent Lat 
1 0.5 -5 .5  1.0 
3 0.55 -5 .6  1.0 
5 0.6 -5 .7  1.l 
7 0.65 -5 .9  1.2 
10 0.7 -6 .4  1.3 
15 0.8 -6 .5  1.4 
(from bregma) 
Following surgery, animals were placed on a heating pad under a 
heating lamp until their behavior resembled those of naive litter- 
mates. The whole litter was returned to the mother as a group. Total 
time of maternal deprivation was 3-4 h. 
Coordinate determination and verification 
PVN coordinates were derived as follows: several animals of each 
age group were implanted with empty cannulae. Cannula placement 
was examined in some animals immediately and in others, three days 
later, to control lor potential brain growth+ 13rains ~u~c removed and 
quickly frozen in powdered dry-ice ~ Twenty /Jm frt>zcn scction~ 
~,,ere cut and every eighth section was stained with ("re'el violet. T im 
verification procedure was also followed at the end ol each implanta 
tion experiment. 
Tissue preparation 
Neonatal rats were sacrificed three days after implantation. Time 
of sacrifice was between 08.00 and 09.30 h, to avoid diurnal variabil- 
ity in CRH-mRNA abundance and CORT levels 1~27. Animals were 
decapitated rapidly, within 25 s of separation from littermates and 
mother. Trunk blood was collected, and brains were removed onto 
dry-ice and stored at - 80°C. Coronal sections (20 ~m) were mounted 
on gelatin-coated slides and stored at -80°C. 
Preparation of CRtt oligonucleotide, and GR-clone probes 
A 60 nucleotide synthetic probe corresponding to the codons for 
the 20 COOH-amino acids of CRH had been generated using an 
Applied Biosystems DNA Synthesizer 2'4. The probe was labeled on 
the Y-end with [35S]-dATP (New England Nuclear) using terminal 
deoxy-nucleotidyl transferase (Bethesda Research Lab). A sense- 
strand and an oligonucleotide probe for somatostatin messenger 
RNA were similarly generated and labeled as specificity controls 2'4. 
A GC receptor-specific clone (originally from Dr. K. Yamada) was 
obtained from Drs. J.P. Herman and S.J. Watson 7. Both sense and 
antisense [35S]-cRNA probes were synthesized using [3SS]-UTP 
(Amersham), and Sp6 and Y 7 RNA polymerase respectively. The 
specific activity of the probes were 1.4x 109 cpm/  ug. 
In situ hybrid&ation procedures 
Prior to ISH, slides were brought o room temperature, air-dried 
and fixed in buffered paraformaldehyde. Following a graded ethanol 
treatment 2'4 sections were exposed to acetic anbydride-tr i -  
ethanolamine, then dehydrated through 100% ethanol 2'2~. 
For CRH-mRNA,  sections were prehybridized for 1 h, then 
hybridized for 20 h at 40°C in a humidity chamberl as described 
elsewhere -''4. Serial washes (2xSSC for 15 rain x4  at 40°C, I x and 
0.4xSSC for 30 rain each at room temperature) were followed by 
dehydration and apposition to film (Hyperfilm B-Max, Amersham). 
Several sections were subsequently dipped in emulsion (NTB-2: 
Kodak), and developed as previously described 2"4, with the exception 
that the emulsion was not diluted. 
The ISH procedure using GC cRNA probes was modified from 
that described by Angerer I and Simmons 2°. Briefly, acetic anhy- 
dride-treated, ethanol dehydrated sections were exposed to 20 #1 
hybridization solution 2° containing 5 x 107 cpm/ml  of labeled probe 
at ~8°C for 15 h. Coverslips were removed in 4 x SSC, and the slides 
treated with 20 /zg/ml RNase A for 30 min at 37°C. Serial washes 
with decreasing concentrations of SSC, containing 1 mM DTT were 
followed by a high stringency wash (0.1 x SSC) at 75°C for 1 h. The 
slides were then dehydrated through ethanol-0.3 M NH4Ac and 
apposed to film. 
Sections with the maximal area of PVN, based on Cresyl violet 
staining, were used for quantitative image analysis. Quantitation and 
statistical analysis were described previously 24. Briefly, optical den- 
sity (OD) was determined over PVN and parietal cortex, as back- 
ground, using the MCID software image analysis system (Imaging 
Research, Ont., Canada). Each point was derived from 6-12 sections 
from a minimum of 6 individual rats. Ratios of PVN to parietal 
cortex were determined as a measure of the abundance of CRH- 
mRNA, thus eliminating background variability with age. Two-way 
analysis of variance (treatment and age), was used to compare OD 
ratios in RU 38486-implanted group to those in cholesterol-im- 
planted or non-implanted controls. 
Radioimmunoassay 
Plasma CORT was assayed using a commercial RIA kit (ICN, 
Irvine, CA), as previously described s. Assay sensitivity for CORT 
was 0.05 ng/ml .  Intra-assay variability was less than 7C~. All samples 
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were run in the same assay. Significant differences between groups 
were assessed by analysis of variance. 
RESULTS 
Effect of implantation on i fant rat weight gain 
There was no effect of cannula implantation 
body weight gain. Fig. 1 shows that neither the stress of 
implantation (cholesterol group) nor RU-38486 con- 
taining cannulae affected body weight for the duration 
of the experiment. On the day of sacrifice, weights of 
cholesterol- and RU 38486-implanted rats were not 
different from those of non-implanted littermates (P > 
0.1, Fig. 1). 
Effect of RU 38486 implantation on plasma CORT leuels 
Plasma CORT did not differ between the non-im- 
planted and cholesterol-implanted groups at any time 
point (Fig. 2). The low hormone levels during the first 
two postnatal weeks are consistent with previous re- 
ports 13"21"2¢'. Plasma CORT levels in RU 38486-im- 
planted pups were higher than those of cholesterol-im- 
planted ones (and of non-implanted controls) starting 
on postnatal day 8 (day of sacrifice, implanted on day 
5, Fig. 2, P = 0.025). 
Effect of RU 38486 implantation on CRH gene expres- 
sion in the PVN 
CRH-mRNA in rats implanted on days 4, 6, 7, 9 and 
10 (sacrificed on days 7, 9, 10, 12 and 13) are shown in 
Fig. 3. A typical dark-field photomicrograph of ISH for 
CRH-mRNA is found in Fig. 4. CRH-mRNA abun- 
dance in rats implanted on day 3 were indistinguish- 
able from those presented for day 4. Similarly, results 
• • b 
Fig. 2. Plasma corticosterone l vels, on day of sacrifice, in choles- 
terol- or RU 38486-implanted and non-implanted neonatal rats. 
Starting on postnatal day 8 (i.e. pups implanted on day 5), cortico- 
sterone levels of RU 38486-implanted rats were significantly higher 
than those of cholesterol-implanted controls (P <0.05, ANOVA). 
Each point represents he mean + S.E.M. of at least 6 rats. 
of implantation on days 5 and 12/13 did not differ 
from those presented for days 6 and 9/10, respectively. 
RU 38486 increased CRH gene expression in the PVN 
when implanted on or subsequent to the 9th postnatal 
day (P < 0.05; Figs. 3, 4). Cholesterol implantation did 
not cause a significant change in CRH gene expression 
when implanted on days 2-6 (Fig. 3). Pups subjected to 
cholesterol-implantation on days 7,9 had a significant 
(P= 0.025) increase in PVN-CRH-mRNA abundance 
compared to non-implanted controls. Cholesterol ira- 
I I 
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F~ 
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50 
?b 
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lo ~ f~ 
C t 
6 
[ i] un implcnted  
[z~] cho les tero l  imp lanted  
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8 17 
X >, 
/ 
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POSI~JArA,  DA~ (day  of sacrb ice)  
Fig. 1. Effects of cholesterol- and RU 38486-implantation on infant 
rat body weight gain. Rats were implanted with cholesterol or RU 
38486 three days before sacrifice. Each bar represents the mean + 
S.E.M. of 6-20 rats. Differences between groups are not significant 
( P > 0.05). 
. LL 
h 
Fig. 3. Effect of cholesterol- and RU 3848B-implantation  CRH- 
mRNA abundance in neonatal rat PVN. Rat pups were sacrificed 3
days after surgery. In pups implanted on days 9, 10 and later (not 
shown), PVN-CRH-mRNA in the RU 38486 group is significantly 
increased compared with both the cholesterol and non-implanted 
controls (P<0.05) .  Differences between CRH-mRNA levels in 
cholesterol-implanted and non-implanted groups are significant on 
day 9 (P < 0.05), but not on day 10 (P = 0.10). Each bar represents 
mean _+ S.E.M. of at least 6 sections from 6 individual rats. 
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plantation on day 10 resulted in a smaller increase in 
CRH-mRNA (P = 0.10, cholesterol-implanted vs. non- 
implanted). 
Presence of GR-mRNA in the PVN 
GC receptor-mRNA was present in the PVN of the 
neonatal rat as early as the first postnatal day (not 
shown). Utilizing ISH, GR-mRNA was confined to the 
parvocellular subdivisions of the nucleus, similar to the 
distribution of CRH-mRNA 2'6'22'29 (Fig. 4). 
DISCUSSION 
We find that during the first postnatal week, neither 
elimination of GC input into the PVN, nor chronic 
stress associated with cannula-implantation result in 
enhanced CRH-mRNA abundance. GC receptor 
blockade at the PVN starting on days 8-9 results in 
enhanced CRH synthesis. The increase in CRH-mRNA 
abundance in rats subjected to implantation stress is 
transient, and is seen in pups implanted on days 7-9 
(sacrificed on days 10-12, Fig. 3). 
These results are subject to several interpretations, 
regarding the development of both the stress response, 
and the CRH-ACTH-GC feedback loop in the neona- 
tal rat. Elimination of the negative feedback effect of 
GC in a mature rat results in up-regulation of CRH 
synthesis s'm'22'2° CORT exerts a dose-dependent nega- 
tive feedback effect on CRH gene expression in the 
PVN =. This effect is at least partially mediated via 
local GC receptors ma1"17'19'22. Our results demonstrate 
that elimination of GC input into the PVN during the 
first postnatal week does not increase CRH-mRNA 
levels. This is in accord with Grino's report that 
adrenalectomy does not alter CRH synthesis in the 
7-day-old rat 5. 
This study demonstrates a dysfunction of GC effect 
on CRH-mRNA at the level of the hypothalamus. 
Since GC receptors are synthesized in the PVN in the 
neonatal rat (ref. 24; Fig. 4), absence of GC receptors 
is an unlikely reason for the lack of CRH-mRNA 
response to RU 38486 implantation. Alternatively it 
may be suggested that RU 38486 did not reach PVN 
GC receptors. This is unlikely for the following rea- 
sons: first, we ascertained steroid elimination from the 
cannulae; second the drug was effective in up-regulat- 
ing CRH synthesis in older, larger rats, where diffusion 
distance is greater. Further, both ipsi- and contralat- 
eral PVN were affected in this study, as has been 
reported for adult rats 1°'1~'>~. 
In this study CRH-mRNA abundance, determined 
by semi-quantitative ISH, was used as a measure of 
CRH synthesis. The technique does not account for 
possible alteration in messenger RNA stability 1. Fur- 
Fig. 4. GC receptor messenger-RNA (GR-mRNA) in the PVN (arrow) of a 7-day-old rat subjected to ISH with GR-mRNA probe. Bar = 1 mm.
PVN, paraventricular nucleus. 
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Fig. 5. Darkfield photomicrograph of the PVN of 14-day-old rats implanted with chronic cannulae three days previously and subjected to in situ 
hybridization for CRH-mRNA.  A: cholesterol control. B: RU 38486. Non-implanted pups' CRH-mRNA abundance did not differ from 
cholesterol-implanted (not shown). Bar = 50 ~m. 
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ther, relatively small ( < 30%) changes in CRH-mRNA 
abundance in the immature rat in response to GC 
receptor blockade may not be detectible. Such increase 
in CRH may account for the discrepancy between the 
effect of GC receptor blockade on CRH-mRNA abun- 
dance and on plasma CORT in rats sacrificed on 
postnatal days 8-1t :  As is evident from Figs. 2 and 3, 
RU 38486 implantation during this age increased 
plasma CORT without significantly altering CRH- 
mRNA. Alternative mechanisms may involve enhanced 
pituitary or adrenal sensitivity to circulating CRH and 
ACTH respectively, or an effect of GC blockade on 
other ACTH secretagogues, uch as vasopressin ~s 
Cholesterol containing-cannulae implantation pre- 
sents both an acute and chronic stressor to the neona- 
tal rat. Maternal separation during surgical procedure 
was relatively short, and likely did not activate the 
brain-adrenal axis. Stanton et al. 2~, suggested that a 
one hour maternal separation had no effect on subse- 
quent stress response, and an eight hour deprivation 
had a modest effect. Further, plasma CORT of mater- 
nally deprived but non-implanted littermate controls in 
the current study were consistent with those reported 
for non-stressed neonatal rats of similar age 13'21'2~'. 
Cholesterol containing cannulae increased CRH- 
mRNA in rats sacrificed on days 10-12 but not later, 
suggesting that for younger pups, carrying a chronic 
cannula was stressful. It further implied that CRH- 
mRNA may be affected by chronic stress at this age. 
Plasma CORT was not increased in these cholesterol 
implanted pups. The independence of plasma ACTH 
and CORT from circulating CRH during the second 
postnatal week has been suggested by Muret ~5 
In conclusion, chronic, local blockade of PVN GC 
receptors by RU-38486, and cannula implantation-in- 
duced stress, do not induce CRH gene expression prior 
to postnatal day 7. Both maneuvers result in up-regu- 
lation of CRH-mRNA synthesis by postnatal day 9. 
Since GR-mRNA is present in the PVN during the 
first postnatal week, second messenger mechanisms, or 
those independent of GC-receptors may account for 
the failure in CRH-mRNA up-regulation. 
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